Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 9/20 | 1.00 |
| ▸ | AGTR2 | P50052 | 9/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8565683 | 0.84 | AGTR2 (0.72) | AGTR1AGTR2 | |
| SCHEMBL9046592 | 0.83 | AGTR1 (0.71) | AGTR1AGTR2 | |
| Potassium SCHEMBL9649979 | 0.83 | AGTR2 (0.71) | AGTR1AGTR2 | |
| SCHEMBL9649960 | 0.83 | AGTR2 (0.71) | AGTR1AGTR2 | |
| SCHEMBL9406616 | 0.83 | AGTR2 (0.71) | AGTR1AGTR2 | |
| SCHEMBL9406623 | 0.83 | AGTR2 (0.71) | AGTR1AGTR2 | |
| Ammonia Solution, Strong SCHEMBL8972558 | 0.83 | AGTR2 (0.71) | AGTR1AGTR2 | |
| SCHEMBL12600260 | 0.80 | AGTR1 (1.00) | AGTR1AGTR2 | |
| L-158809 SCHEMBL29486794 | 0.80 | AGTR2 (1.00) | AGTR1AGTR2 | |
| L-158809 SCHEMBL30804020 | 0.80 | AGTR2 (1.00) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230398146-A1 | IMMUNE MODULATION OF MYELOID DERIVED SUPPRESSIVE CELL FUNCTION FOR CANCER TREATMENT | SURGE Therapeutics, Inc. | 2023-12-14 | — | — | US | disclosed |
| EP-4196122-A1 | IMMUNE MODULATION OF MYELOID DERIVED SUPPRESSIVE CELL FUNCTION FOR CANCER TREATMENT | Surge Therapeutics, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| CN-110156761-B | Compound containing coumarin-biphenyl skeleton, preparation method and application thereof | 郑州大学 | 2022-08-09 | — | — | CN | disclosed |
| WO-2022040246-A1 | IMMUNE MODULATION OF MYELOID DERIVED SUPPRESSIVE CELL FUNCTION FOR CANCER TREATMENT | STIMIT CORPORATION (US) | 2022-02-24 | — | — | WO | disclosed |